Ian R. Friedland
Geen lopende functies
Profiel
Ian R.
Friedland worked as a Vice President-Clinical Development at Cubist Pharmaceuticals LLC, Senior Director at Johnson & Johnson Pharmaceutical Group, Senior Director at Peninsula Pharmaceuticals, Inc., and Director-Clinical Research at Merck & Co., Inc. He also served as the Chief Medical Officer at Achaogen, Inc. and Calixa Therapeutics, Inc. Dr. Friedland holds a doctorate degree from the University of the Witwatersrand.
Eerdere bekende functies van Ian R. Friedland
Bedrijven | Functie | Einde |
---|---|---|
ACHAOGEN | Hoofd Techniek/Wetenschap/O&O | 15-03-2017 |
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 01-12-2009 |
MERCK & CO., INC. | Corporate Officer/Principal | - |
CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Directeur/Bestuurslid | - |
Opleiding van Ian R. Friedland
University of the Witwatersrand | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | Health Technology |
Johnson & Johnson Pharmaceutical Group | |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | Commercial Services |
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |